Search

everythinglearnresearchcommunity

for

Search:↓

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Acne necrotica can be effectively treated with topical cream and antibiotics.

Juvenile-onset lupus patients have more severe symptoms and need stronger treatment.

A patient with a larger than usual genetic mutation had a broader range of symptoms for a muscle disease.

Late onset SLE has different symptoms and antibody profiles compared to young onset SLE.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Avoiding smoking, stress, obesity, and poor diet may help reduce hair loss in young Egyptian males.

Stem cell niches are crucial for regulating stem cell behavior and tissue health, and their decline can impact aging and cancer.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Higher IL-17A levels indicate more severe alopecia areata.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

It's unclear if COVID-19 vaccination causes SLE; more research is needed.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

Toxic Shock Syndrome cases increased due to new factors, but decreased with public health measures and changes in tampon use.

Oxidative stress increases in early hair loss, and family history plays a role; antioxidants may help future treatments.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

The document says how to diagnose and treat hair loss from alopecia areata, but there's no cure and treatments vary.

A girl with type 1 diabetes developed a serious eye condition very early, suggesting the need for earlier eye checks and that early treatment can work well.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Men with Kennedy disease have less chance of hair loss.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

The index to ring finger ratio may indicate disease severity in female ankylosing spondylitis patients, but not in males.